| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.80▲ | 5.88▼ | 5.86▼ | 6.13▼ | 5.48▲ |
| MA10 | 5.83▼ | 5.98▼ | 6.01▼ | 5.77▲ | 5.75▲ |
| MA20 | 6.04▼ | 6.21▼ | 6.26▼ | 5.65▲ | 7.02▼ |
| MA50 | 6.28▼ | 6.21▼ | 5.98▼ | 5.90▼ | 4.85▲ |
| MA100 | 6.14▼ | 5.79▲ | 5.73▲ | 7.37▼ | 2.97▲ |
| MA200 | 5.80▲ | 5.62▲ | 5.84▼ | 5.79▲ | 2.83▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.022▼ | -0.065▼ | -0.088▼ | 0.129▲ | -0.357▼ |
| RSI | 37.406▼ | 39.027▼ | 41.510▼ | 50.465▲ | 48.016▼ |
| STOCH | 19.822▼ | 18.537▼ | 13.083▼ | 71.299 | 36.070 |
| WILL %R | -86.486▼ | -89.865▼ | -91.935▼ | -50.811 | -66.262 |
| CCI | -56.145 | -80.940 | -95.792 | 38.394 | -3.368 |
|
Monday, January 12, 2026 03:16 PM
CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and ...
|
|
Monday, July 14, 2025 01:05 PM
VIENNA, Va.--(BUSINESS WIRE)-- CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the closing of its best-efforts ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/01/26 | 6.28 | 6.28 | 5.735 | 5.81 | 83,790 |
| 28/01/26 | 6.61 | 6.68 | 6.10 | 6.30 | 87,202 |
| 27/01/26 | 6.3962 | 6.72 | 6.3962 | 6.51 | 146,364 |
| 26/01/26 | 6.70 | 6.75 | 5.985 | 6.18 | 210,810 |
| 23/01/26 | 6.33 | 6.4086 | 5.82 | 5.83 | 64,561 |
| 22/01/26 | 5.32 | 6.56 | 5.32 | 6.41 | 127,765 |
| 21/01/26 | 5.28 | 5.68 | 5.25 | 5.26 | 33,240 |
| 20/01/26 | 5.16 | 5.8777 | 5.02 | 5.25 | 93,815 |
| 16/01/26 | 5.43 | 5.495 | 4.91 | 5.15 | 78,240 |
| 15/01/26 | 5.23 | 5.28 | 4.90 | 4.99 | 73,326 |
|
|
||||
|
|
||||
|
|